Shattuck Labs (STTK) Liabilities and Shareholders Equity (2019 - 2026)

Shattuck Labs (STTK) reported Liabilities and Shareholders Equity of $102.1 million for Q1 2026, up 32.34% year-over-year from $77.2 million in Q1 2025, and up 12.19% quarter-over-quarter from $91.0 million in Q4 2025.

Shattuck Labs (STTK) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $102.1 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $102.1 million, up 32.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $357.9 million (down 12.41% YoY), and the FY2025 annual result was $91.0 million, changed 0.03% from the prior year.
  • Liabilities and Shareholders Equity rose to $102.1 million in Q1 2026 per STTK's latest filing, from $91.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $270.5 million in Q1 2022 and troughed at $64.4 million in Q2 2025.
  • A 5-year average of $146.2 million and a median of $130.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity tumbled 49.95% in 2025, then surged 32.34% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $205.3 million in 2022, then fell by 22.29% to $159.6 million in 2023, then plunged by 42.94% to $91.0 million in 2024, then fell by 0.03% to $91.0 million in 2025, then advanced by 12.19% to $102.1 million in 2026.
  • Business Quant data shows STTK's Liabilities and Shareholders Equity at $102.1 million in Q1 2026, $91.0 million in Q4 2025, and $100.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Shattuck Labs 190.32 Mn 190.32 Mn - 102.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 102.12 Mn
Dec 31, 2025 91.03 Mn
Sep 30, 2025 100.33 Mn
Jun 30, 2025 64.37 Mn
Mar 31, 2025 77.17 Mn
Dec 31, 2024 91.05 Mn
Sep 30, 2024 111.72 Mn
Jun 30, 2024 128.61 Mn
Mar 31, 2024 146.34 Mn
Dec 31, 2023 159.56 Mn
Sep 30, 2023 130.46 Mn
Jun 30, 2023 155.27 Mn
Mar 31, 2023 177.68 Mn
Dec 31, 2022 205.32 Mn
Sep 30, 2022 222.94 Mn
Jun 30, 2022 251.34 Mn
Mar 31, 2022 270.49 Mn
Dec 31, 2021 298.59 Mn
Sep 30, 2021 310.57 Mn
Jun 30, 2021 323.78 Mn